nodes	percent_of_prediction	percent_of_DWPC	metapath
Phendimetrazine—Blood pressure increased—Pazopanib—kidney cancer	0.0256	0.027	CcSEcCtD
Phendimetrazine—Blood pressure increased—Sorafenib—kidney cancer	0.0176	0.0185	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Pazopanib—kidney cancer	0.017	0.0179	CcSEcCtD
Phendimetrazine—Blood pressure increased—Sunitinib—kidney cancer	0.0169	0.0178	CcSEcCtD
Phendimetrazine—Dysuria—Temsirolimus—kidney cancer	0.016	0.0168	CcSEcCtD
Phendimetrazine—Pollakiuria—Temsirolimus—kidney cancer	0.0158	0.0166	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Everolimus—kidney cancer	0.0134	0.0141	CcSEcCtD
Phendimetrazine—Flushing—Pazopanib—kidney cancer	0.0119	0.0126	CcSEcCtD
Phendimetrazine—Dysuria—Everolimus—kidney cancer	0.0119	0.0125	CcSEcCtD
Phendimetrazine—Pollakiuria—Everolimus—kidney cancer	0.0117	0.0124	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Sorafenib—kidney cancer	0.0116	0.0123	CcSEcCtD
Phendimetrazine—Blood pressure increased—Paclitaxel—kidney cancer	0.0114	0.012	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Sunitinib—kidney cancer	0.0112	0.0118	CcSEcCtD
Phendimetrazine—Vision blurred—Pazopanib—kidney cancer	0.0106	0.0111	CcSEcCtD
Phendimetrazine—Flushing—Everolimus—kidney cancer	0.00943	0.00995	CcSEcCtD
Phendimetrazine—Blood pressure increased—Capecitabine—kidney cancer	0.00932	0.00983	CcSEcCtD
Phendimetrazine—Anorexia—Temsirolimus—kidney cancer	0.00925	0.00976	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Pazopanib—kidney cancer	0.00884	0.00932	CcSEcCtD
Phendimetrazine—Insomnia—Temsirolimus—kidney cancer	0.00878	0.00926	CcSEcCtD
Phendimetrazine—Anorexia—Pazopanib—kidney cancer	0.00872	0.00919	CcSEcCtD
Phendimetrazine—Decreased appetite—Temsirolimus—kidney cancer	0.00844	0.0089	CcSEcCtD
Phendimetrazine—Dysuria—Vincristine—kidney cancer	0.00839	0.00885	CcSEcCtD
Phendimetrazine—Vision blurred—Everolimus—kidney cancer	0.00834	0.00879	CcSEcCtD
Phendimetrazine—Constipation—Temsirolimus—kidney cancer	0.0083	0.00875	CcSEcCtD
Phendimetrazine—Tremor—Everolimus—kidney cancer	0.00829	0.00874	CcSEcCtD
Phendimetrazine—Insomnia—Pazopanib—kidney cancer	0.00827	0.00872	CcSEcCtD
Phendimetrazine—Flushing—Sorafenib—kidney cancer	0.00819	0.00863	CcSEcCtD
Phendimetrazine—Agitation—Everolimus—kidney cancer	0.00813	0.00857	CcSEcCtD
Phendimetrazine—Decreased appetite—Pazopanib—kidney cancer	0.00795	0.00838	CcSEcCtD
Phendimetrazine—Flushing—Sunitinib—kidney cancer	0.00788	0.00831	CcSEcCtD
Phendimetrazine—Palpitations—Everolimus—kidney cancer	0.00782	0.00824	CcSEcCtD
Phendimetrazine—Abdominal pain—Temsirolimus—kidney cancer	0.00767	0.00809	CcSEcCtD
Phendimetrazine—Sweating—Vincristine—kidney cancer	0.00767	0.00809	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Paclitaxel—kidney cancer	0.00753	0.00794	CcSEcCtD
Phendimetrazine—Flushing—Dactinomycin—kidney cancer	0.00746	0.00786	CcSEcCtD
Phendimetrazine—Sweating—Gemcitabine—kidney cancer	0.00727	0.00767	CcSEcCtD
Phendimetrazine—Abdominal pain—Pazopanib—kidney cancer	0.00723	0.00762	CcSEcCtD
Phendimetrazine—Tachycardia—Everolimus—kidney cancer	0.00705	0.00743	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Everolimus—kidney cancer	0.00698	0.00736	CcSEcCtD
Phendimetrazine—Anorexia—Vinblastine—kidney cancer	0.00691	0.00729	CcSEcCtD
Phendimetrazine—Anorexia—Everolimus—kidney cancer	0.00688	0.00726	CcSEcCtD
Phendimetrazine—Dysuria—Paclitaxel—kidney cancer	0.00666	0.00703	CcSEcCtD
Phendimetrazine—Diarrhoea—Temsirolimus—kidney cancer	0.00664	0.007	CcSEcCtD
Phendimetrazine—Anorexia—Erlotinib—kidney cancer	0.00664	0.007	CcSEcCtD
Phendimetrazine—Pollakiuria—Paclitaxel—kidney cancer	0.00658	0.00694	CcSEcCtD
Phendimetrazine—Insomnia—Everolimus—kidney cancer	0.00653	0.00689	CcSEcCtD
Phendimetrazine—Dizziness—Temsirolimus—kidney cancer	0.00642	0.00677	CcSEcCtD
Phendimetrazine—Insomnia—Erlotinib—kidney cancer	0.0063	0.00664	CcSEcCtD
Phendimetrazine—Decreased appetite—Vinblastine—kidney cancer	0.0063	0.00664	CcSEcCtD
Phendimetrazine—Decreased appetite—Everolimus—kidney cancer	0.00628	0.00662	CcSEcCtD
Phendimetrazine—Diarrhoea—Pazopanib—kidney cancer	0.00626	0.0066	CcSEcCtD
Phendimetrazine—Constipation—Vinblastine—kidney cancer	0.0062	0.00654	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Capecitabine—kidney cancer	0.00618	0.00652	CcSEcCtD
Phendimetrazine—Constipation—Everolimus—kidney cancer	0.00617	0.00651	CcSEcCtD
Phendimetrazine—Headache—Temsirolimus—kidney cancer	0.00608	0.00641	CcSEcCtD
Phendimetrazine—Decreased appetite—Erlotinib—kidney cancer	0.00605	0.00639	CcSEcCtD
Phendimetrazine—Dizziness—Pazopanib—kidney cancer	0.00605	0.00638	CcSEcCtD
Phendimetrazine—Anorexia—Sorafenib—kidney cancer	0.00597	0.0063	CcSEcCtD
Phendimetrazine—Constipation—Erlotinib—kidney cancer	0.00596	0.00628	CcSEcCtD
Phendimetrazine—Nausea—Temsirolimus—kidney cancer	0.00576	0.00608	CcSEcCtD
Phendimetrazine—Anorexia—Sunitinib—kidney cancer	0.00575	0.00606	CcSEcCtD
Phendimetrazine—Agitation—Vincristine—kidney cancer	0.00574	0.00606	CcSEcCtD
Phendimetrazine—Abdominal pain—Vinblastine—kidney cancer	0.00573	0.00604	CcSEcCtD
Phendimetrazine—Headache—Pazopanib—kidney cancer	0.00573	0.00604	CcSEcCtD
Phendimetrazine—Abdominal pain—Everolimus—kidney cancer	0.00571	0.00602	CcSEcCtD
Phendimetrazine—Abdominal pain—Erlotinib—kidney cancer	0.00551	0.00581	CcSEcCtD
Phendimetrazine—Dysuria—Capecitabine—kidney cancer	0.00547	0.00577	CcSEcCtD
Phendimetrazine—Insomnia—Sunitinib—kidney cancer	0.00545	0.00575	CcSEcCtD
Phendimetrazine—Decreased appetite—Sorafenib—kidney cancer	0.00545	0.00575	CcSEcCtD
Phendimetrazine—Anorexia—Dactinomycin—kidney cancer	0.00544	0.00574	CcSEcCtD
Phendimetrazine—Nausea—Pazopanib—kidney cancer	0.00543	0.00573	CcSEcCtD
Phendimetrazine—Constipation—Sorafenib—kidney cancer	0.00536	0.00565	CcSEcCtD
Phendimetrazine—Flushing—Paclitaxel—kidney cancer	0.00529	0.00558	CcSEcCtD
Phendimetrazine—Decreased appetite—Sunitinib—kidney cancer	0.00524	0.00553	CcSEcCtD
Phendimetrazine—Constipation—Sunitinib—kidney cancer	0.00516	0.00544	CcSEcCtD
Phendimetrazine—Decreased appetite—Dactinomycin—kidney cancer	0.00496	0.00523	CcSEcCtD
Phendimetrazine—Diarrhoea—Vinblastine—kidney cancer	0.00496	0.00523	CcSEcCtD
Phendimetrazine—Abdominal pain—Sorafenib—kidney cancer	0.00495	0.00522	CcSEcCtD
Phendimetrazine—Diarrhoea—Everolimus—kidney cancer	0.00494	0.00521	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Vincristine—kidney cancer	0.00493	0.0052	CcSEcCtD
Phendimetrazine—Anorexia—Vincristine—kidney cancer	0.00486	0.00513	CcSEcCtD
Phendimetrazine—Dizziness—Vinblastine—kidney cancer	0.00479	0.00505	CcSEcCtD
Phendimetrazine—Dizziness—Everolimus—kidney cancer	0.00477	0.00504	CcSEcCtD
Phendimetrazine—Abdominal pain—Sunitinib—kidney cancer	0.00477	0.00503	CcSEcCtD
Phendimetrazine—Diarrhoea—Erlotinib—kidney cancer	0.00477	0.00503	CcSEcCtD
Phendimetrazine—Vision blurred—Paclitaxel—kidney cancer	0.00468	0.00493	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Gemcitabine—kidney cancer	0.00468	0.00493	CcSEcCtD
Phendimetrazine—Tremor—Paclitaxel—kidney cancer	0.00465	0.0049	CcSEcCtD
Phendimetrazine—Insomnia—Vincristine—kidney cancer	0.00461	0.00487	CcSEcCtD
Phendimetrazine—Anorexia—Gemcitabine—kidney cancer	0.00461	0.00486	CcSEcCtD
Phendimetrazine—Dizziness—Erlotinib—kidney cancer	0.00461	0.00486	CcSEcCtD
Phendimetrazine—Agitation—Paclitaxel—kidney cancer	0.00456	0.00481	CcSEcCtD
Phendimetrazine—Headache—Vinblastine—kidney cancer	0.00454	0.00479	CcSEcCtD
Phendimetrazine—Headache—Everolimus—kidney cancer	0.00452	0.00477	CcSEcCtD
Phendimetrazine—Abdominal pain—Dactinomycin—kidney cancer	0.00451	0.00476	CcSEcCtD
Phendimetrazine—Decreased appetite—Vincristine—kidney cancer	0.00443	0.00468	CcSEcCtD
Phendimetrazine—Palpitations—Paclitaxel—kidney cancer	0.00439	0.00463	CcSEcCtD
Phendimetrazine—Insomnia—Gemcitabine—kidney cancer	0.00438	0.00462	CcSEcCtD
Phendimetrazine—Headache—Erlotinib—kidney cancer	0.00436	0.0046	CcSEcCtD
Phendimetrazine—Constipation—Vincristine—kidney cancer	0.00436	0.0046	CcSEcCtD
Phendimetrazine—Flushing—Capecitabine—kidney cancer	0.00434	0.00458	CcSEcCtD
Phendimetrazine—Nausea—Vinblastine—kidney cancer	0.0043	0.00454	CcSEcCtD
Phendimetrazine—Nausea—Everolimus—kidney cancer	0.00429	0.00452	CcSEcCtD
Phendimetrazine—Diarrhoea—Sorafenib—kidney cancer	0.00429	0.00452	CcSEcCtD
Phendimetrazine—Decreased appetite—Gemcitabine—kidney cancer	0.00421	0.00444	CcSEcCtD
Phendimetrazine—Dizziness—Sorafenib—kidney cancer	0.00414	0.00437	CcSEcCtD
Phendimetrazine—Constipation—Gemcitabine—kidney cancer	0.00414	0.00436	CcSEcCtD
Phendimetrazine—Nausea—Erlotinib—kidney cancer	0.00414	0.00436	CcSEcCtD
Phendimetrazine—Diarrhoea—Sunitinib—kidney cancer	0.00413	0.00435	CcSEcCtD
Phendimetrazine—Abdominal pain—Vincristine—kidney cancer	0.00403	0.00425	CcSEcCtD
Phendimetrazine—Dizziness—Sunitinib—kidney cancer	0.00399	0.00421	CcSEcCtD
Phendimetrazine—Abdominal pain upper—Doxorubicin—kidney cancer	0.00398	0.0042	CcSEcCtD
Phendimetrazine—Tachycardia—Paclitaxel—kidney cancer	0.00395	0.00417	CcSEcCtD
Phendimetrazine—Headache—Sorafenib—kidney cancer	0.00393	0.00414	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00392	0.00413	CcSEcCtD
Phendimetrazine—Diarrhoea—Dactinomycin—kidney cancer	0.00391	0.00412	CcSEcCtD
Phendimetrazine—Anorexia—Paclitaxel—kidney cancer	0.00386	0.00407	CcSEcCtD
Phendimetrazine—Vision blurred—Capecitabine—kidney cancer	0.00384	0.00405	CcSEcCtD
Phendimetrazine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—ACHE—kidney cancer	0.00383	0.0737	CbGpPWpGaD
Phendimetrazine—Tremor—Capecitabine—kidney cancer	0.00382	0.00403	CcSEcCtD
Phendimetrazine—Headache—Sunitinib—kidney cancer	0.00378	0.00398	CcSEcCtD
Phendimetrazine—Nausea—Sorafenib—kidney cancer	0.00372	0.00393	CcSEcCtD
Phendimetrazine—Insomnia—Paclitaxel—kidney cancer	0.00366	0.00386	CcSEcCtD
Phendimetrazine—Palpitations—Capecitabine—kidney cancer	0.0036	0.0038	CcSEcCtD
Phendimetrazine—Nausea—Sunitinib—kidney cancer	0.00358	0.00378	CcSEcCtD
Phendimetrazine—Dysuria—Doxorubicin—kidney cancer	0.00352	0.00372	CcSEcCtD
Phendimetrazine—Decreased appetite—Paclitaxel—kidney cancer	0.00352	0.00371	CcSEcCtD
Phendimetrazine—Diarrhoea—Vincristine—kidney cancer	0.00349	0.00368	CcSEcCtD
Phendimetrazine—Pollakiuria—Doxorubicin—kidney cancer	0.00348	0.00367	CcSEcCtD
Phendimetrazine—Constipation—Paclitaxel—kidney cancer	0.00346	0.00365	CcSEcCtD
Phendimetrazine—Nausea—Dactinomycin—kidney cancer	0.00339	0.00358	CcSEcCtD
Phendimetrazine—Dizziness—Vincristine—kidney cancer	0.00337	0.00356	CcSEcCtD
Phendimetrazine—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—kidney cancer	0.00333	0.0642	CbGpPWpGaD
Phendimetrazine—Diarrhoea—Gemcitabine—kidney cancer	0.00331	0.00349	CcSEcCtD
Phendimetrazine—Tachycardia—Capecitabine—kidney cancer	0.00324	0.00342	CcSEcCtD
Phendimetrazine—Sweating—Doxorubicin—kidney cancer	0.00322	0.0034	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Capecitabine—kidney cancer	0.00321	0.00339	CcSEcCtD
Phendimetrazine—Abdominal pain—Paclitaxel—kidney cancer	0.0032	0.00338	CcSEcCtD
Phendimetrazine—Headache—Vincristine—kidney cancer	0.0032	0.00337	CcSEcCtD
Phendimetrazine—Anorexia—Capecitabine—kidney cancer	0.00317	0.00334	CcSEcCtD
Phendimetrazine—Headache—Gemcitabine—kidney cancer	0.00303	0.0032	CcSEcCtD
Phendimetrazine—Nausea—Vincristine—kidney cancer	0.00303	0.0032	CcSEcCtD
Phendimetrazine—Insomnia—Capecitabine—kidney cancer	0.00301	0.00317	CcSEcCtD
Phendimetrazine—Decreased appetite—Capecitabine—kidney cancer	0.00289	0.00305	CcSEcCtD
Phendimetrazine—Nausea—Gemcitabine—kidney cancer	0.00287	0.00303	CcSEcCtD
Phendimetrazine—Constipation—Capecitabine—kidney cancer	0.00284	0.003	CcSEcCtD
Phendimetrazine—Flushing—Doxorubicin—kidney cancer	0.0028	0.00295	CcSEcCtD
Phendimetrazine—Diarrhoea—Paclitaxel—kidney cancer	0.00277	0.00292	CcSEcCtD
Phendimetrazine—Dizziness—Paclitaxel—kidney cancer	0.00268	0.00283	CcSEcCtD
Phendimetrazine—Abdominal pain—Capecitabine—kidney cancer	0.00263	0.00277	CcSEcCtD
Phendimetrazine—Headache—Paclitaxel—kidney cancer	0.00254	0.00268	CcSEcCtD
Phendimetrazine—Vision blurred—Doxorubicin—kidney cancer	0.00247	0.00261	CcSEcCtD
Phendimetrazine—Agitation—Doxorubicin—kidney cancer	0.00241	0.00254	CcSEcCtD
Phendimetrazine—Nausea—Paclitaxel—kidney cancer	0.00241	0.00254	CcSEcCtD
Phendimetrazine—Palpitations—Doxorubicin—kidney cancer	0.00232	0.00245	CcSEcCtD
Phendimetrazine—Diarrhoea—Capecitabine—kidney cancer	0.00227	0.0024	CcSEcCtD
Phendimetrazine—SLC6A3—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.00226	0.0436	CbGpPWpGaD
Phendimetrazine—Dizziness—Capecitabine—kidney cancer	0.0022	0.00232	CcSEcCtD
Phendimetrazine—Tachycardia—Doxorubicin—kidney cancer	0.00209	0.00221	CcSEcCtD
Phendimetrazine—Headache—Capecitabine—kidney cancer	0.00208	0.0022	CcSEcCtD
Phendimetrazine—Hyperhidrosis—Doxorubicin—kidney cancer	0.00207	0.00218	CcSEcCtD
Phendimetrazine—Anorexia—Doxorubicin—kidney cancer	0.00204	0.00215	CcSEcCtD
Phendimetrazine—Nausea—Capecitabine—kidney cancer	0.00197	0.00208	CcSEcCtD
Phendimetrazine—SLC6A3—Parkinsons Disease Pathway—LRRK2—kidney cancer	0.00196	0.0378	CbGpPWpGaD
Phendimetrazine—Insomnia—Doxorubicin—kidney cancer	0.00194	0.00204	CcSEcCtD
Phendimetrazine—Decreased appetite—Doxorubicin—kidney cancer	0.00186	0.00196	CcSEcCtD
Phendimetrazine—Constipation—Doxorubicin—kidney cancer	0.00183	0.00193	CcSEcCtD
Phendimetrazine—Abdominal pain—Doxorubicin—kidney cancer	0.00169	0.00179	CcSEcCtD
Phendimetrazine—Diarrhoea—Doxorubicin—kidney cancer	0.00147	0.00155	CcSEcCtD
Phendimetrazine—SLC6A2—Monoamine Transport—ACHE—kidney cancer	0.00142	0.0274	CbGpPWpGaD
Phendimetrazine—SLC6A3—Parkinsons Disease Pathway—CASP2—kidney cancer	0.00142	0.0273	CbGpPWpGaD
Phendimetrazine—Dizziness—Doxorubicin—kidney cancer	0.00142	0.00149	CcSEcCtD
Phendimetrazine—Headache—Doxorubicin—kidney cancer	0.00134	0.00142	CcSEcCtD
Phendimetrazine—SLC6A3—Parkinsons Disease Pathway—APAF1—kidney cancer	0.00133	0.0257	CbGpPWpGaD
Phendimetrazine—Nausea—Doxorubicin—kidney cancer	0.00127	0.00134	CcSEcCtD
Phendimetrazine—SLC6A3—Monoamine Transport—ACHE—kidney cancer	0.00126	0.0243	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—EEF2—kidney cancer	0.00101	0.0195	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000957	0.0184	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—RYR1—kidney cancer	0.000912	0.0176	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—EEF2—kidney cancer	0.000899	0.0173	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000848	0.0163	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—RYR1—kidney cancer	0.00081	0.0156	CbGpPWpGaD
Phendimetrazine—SLC6A2—Monoamine Transport—TSC2—kidney cancer	0.000763	0.0147	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (12/13) signalling events—AKAP13—kidney cancer	0.000717	0.0138	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SLC5A3—kidney cancer	0.00069	0.0133	CbGpPWpGaD
Phendimetrazine—SLC6A3—Monoamine Transport—TSC2—kidney cancer	0.000676	0.013	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (12/13) signalling events—AKAP13—kidney cancer	0.000637	0.0123	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SLC5A3—kidney cancer	0.000611	0.0118	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—GJB1—kidney cancer	0.000604	0.0116	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—KEAP1—kidney cancer	0.000603	0.0116	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—EIF4EBP1—kidney cancer	0.000588	0.0113	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—TSC1—kidney cancer	0.000546	0.0105	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—GJB1—kidney cancer	0.000537	0.0103	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—KEAP1—kidney cancer	0.000534	0.0103	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—EIF4EBP1—kidney cancer	0.000522	0.0101	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—TSC1—kidney cancer	0.000485	0.00935	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000435	0.00838	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000385	0.00742	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000385	0.00741	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SLC5A5—kidney cancer	0.000364	0.00701	CbGpPWpGaD
Phendimetrazine—ADRA1A—Endothelin Pathways—RAF1—kidney cancer	0.000354	0.00681	CbGpPWpGaD
Phendimetrazine—ADRA1B—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	0.000352	0.00678	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—SLC2A1—kidney cancer	0.000352	0.00677	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000341	0.00657	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—EGR1—kidney cancer	0.000326	0.00629	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SLC5A5—kidney cancer	0.000322	0.00621	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—TSC2—kidney cancer	0.000318	0.00613	CbGpPWpGaD
Phendimetrazine—ADRA1A—Calcium Regulation in the Cardiac Cell—ITPR2—kidney cancer	0.000313	0.00603	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—SLC2A1—kidney cancer	0.000311	0.006	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—KCNMA1—kidney cancer	0.000302	0.00581	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—ITPR2—kidney cancer	0.000294	0.00566	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—GSTP1—kidney cancer	0.000293	0.00565	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000291	0.00561	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—EGR1—kidney cancer	0.000289	0.00557	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—TSC2—kidney cancer	0.000283	0.00545	CbGpPWpGaD
Phendimetrazine—SLC6A2—NRF2 pathway—GSTM1—kidney cancer	0.000269	0.00519	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000263	0.00506	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—ITPR2—kidney cancer	0.000261	0.00502	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—GSTP1—kidney cancer	0.00026	0.005	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000254	0.00489	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—ANXA1—kidney cancer	0.000246	0.00474	CbGpPWpGaD
Phendimetrazine—ADRA1A—Endothelin Pathways—MAPK1—kidney cancer	0.000243	0.00467	CbGpPWpGaD
Phendimetrazine—SLC6A3—NRF2 pathway—GSTM1—kidney cancer	0.000239	0.0046	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—OR4C13—kidney cancer	0.000237	0.00457	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—RELA—kidney cancer	0.000233	0.0045	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR2—kidney cancer	0.000233	0.00449	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000229	0.00442	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—ACHE—kidney cancer	0.000223	0.0043	CbGpPWpGaD
Phendimetrazine—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000222	0.00427	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000221	0.00426	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000221	0.00426	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000221	0.00426	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.00022	0.00424	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—ANXA1—kidney cancer	0.000219	0.00421	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—MTOR—kidney cancer	0.000215	0.00415	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—OR4C13—kidney cancer	0.000215	0.00415	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—OR4C13—kidney cancer	0.000211	0.00406	CbGpPWpGaD
Phendimetrazine—ADRA1B—LPA receptor mediated events—JUN—kidney cancer	0.000204	0.00394	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000203	0.00392	CbGpPWpGaD
Phendimetrazine—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000196	0.00378	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000196	0.00377	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000196	0.00377	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000196	0.00377	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	0.000195	0.00377	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—BCHE—kidney cancer	0.000194	0.00375	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—MTOR—kidney cancer	0.000191	0.00369	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—OR4C13—kidney cancer	0.000191	0.00368	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000163	0.00314	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	0.000145	0.00279	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—PIK3CA—kidney cancer	0.000131	0.00253	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—BRAF—kidney cancer	0.00013	0.0025	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—OR4C13—kidney cancer	0.000127	0.00245	CbGpPWpGaD
Phendimetrazine—ADRA1B—AMPK Signaling—TP53—kidney cancer	0.000127	0.00245	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—ANXA1—kidney cancer	0.000124	0.00239	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (12/13) signalling events—PIK3CA—kidney cancer	0.000123	0.00237	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—PIK3CA—kidney cancer	0.000117	0.00225	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000117	0.00225	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—OR4C13—kidney cancer	0.000113	0.00218	CbGpPWpGaD
Phendimetrazine—ADRA1A—AMPK Signaling—TP53—kidney cancer	0.000113	0.00217	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000113	0.00217	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—ANXA1—kidney cancer	0.00011	0.00212	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (12/13) signalling events—PIK3CA—kidney cancer	0.000109	0.0021	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000108	0.00208	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—LATS1—kidney cancer	0.000108	0.00208	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000103	0.00199	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.97e-05	0.00192	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—BRAF—kidney cancer	9.92e-05	0.00191	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—AKAP13—kidney cancer	9.84e-05	0.0019	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—LATS1—kidney cancer	9.6e-05	0.00185	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AMER1—kidney cancer	9.19e-05	0.00177	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—AKAP13—kidney cancer	8.94e-05	0.00172	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	8.89e-05	0.00171	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	8.89e-05	0.00171	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—AKAP13—kidney cancer	8.74e-05	0.00168	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ITPR2—kidney cancer	8.37e-05	0.00161	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—RAF1—kidney cancer	8.28e-05	0.0016	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AMER1—kidney cancer	8.16e-05	0.00157	CbGpPWpGaD
Phendimetrazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.98e-05	0.00154	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—AKAP13—kidney cancer	7.94e-05	0.00153	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	7.9e-05	0.00152	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.87e-05	0.00152	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GPC3—kidney cancer	7.7e-05	0.00148	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CER1—kidney cancer	7.7e-05	0.00148	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ITPR2—kidney cancer	7.6e-05	0.00146	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ITPR2—kidney cancer	7.43e-05	0.00143	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmission across Chemical Synapses—MAPK1—kidney cancer	7.42e-05	0.00143	CbGpPWpGaD
Phendimetrazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	7.09e-05	0.00137	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—ANXA1—kidney cancer	7.01e-05	0.00135	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CER1—kidney cancer	6.84e-05	0.00132	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GPC3—kidney cancer	6.84e-05	0.00132	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ITPR2—kidney cancer	6.75e-05	0.0013	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—SFRP2—kidney cancer	6.55e-05	0.00126	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	6.41e-05	0.00123	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—ANXA1—kidney cancer	6.37e-05	0.00123	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—ANXA1—kidney cancer	6.23e-05	0.0012	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	6.1e-05	0.00117	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR ligand binding—POMC—kidney cancer	6.08e-05	0.00117	CbGpPWpGaD
Phendimetrazine—ADRA1B—G alpha (q) signalling events—PIK3CA—kidney cancer	5.92e-05	0.00114	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—SFRP2—kidney cancer	5.82e-05	0.00112	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	5.76e-05	0.00111	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	5.69e-05	0.0011	CbGpPWpGaD
Phendimetrazine—SLC6A3—Neuronal System—MAPK1—kidney cancer	5.68e-05	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—ANXA1—kidney cancer	5.66e-05	0.00109	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	5.42e-05	0.00104	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR ligand binding—POMC—kidney cancer	5.4e-05	0.00104	CbGpPWpGaD
Phendimetrazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	5.29e-05	0.00102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—AKAP13—kidney cancer	5.28e-05	0.00102	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CASP2—kidney cancer	5.28e-05	0.00102	CbGpPWpGaD
Phendimetrazine—ADRA1A—G alpha (q) signalling events—PIK3CA—kidney cancer	5.25e-05	0.00101	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	5.11e-05	0.000986	CbGpPWpGaD
Phendimetrazine—SLC6A2—Transmembrane transport of small molecules—RAF1—kidney cancer	5.03e-05	0.000969	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—GRB7—kidney cancer	4.83e-05	0.00093	CbGpPWpGaD
Phendimetrazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	4.7e-05	0.000905	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—AKAP13—kidney cancer	4.69e-05	0.000904	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CASP2—kidney cancer	4.69e-05	0.000904	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ITPR2—kidney cancer	4.49e-05	0.000865	CbGpPWpGaD
Phendimetrazine—SLC6A3—Transmembrane transport of small molecules—RAF1—kidney cancer	4.45e-05	0.000858	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—GRB7—kidney cancer	4.29e-05	0.000826	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CTNNA1—kidney cancer	4.07e-05	0.000784	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—EIF4EBP1—kidney cancer	4.05e-05	0.00078	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HSPB1—kidney cancer	4.05e-05	0.00078	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ITPR2—kidney cancer	3.99e-05	0.000768	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PSMD7—kidney cancer	3.76e-05	0.000725	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TSC1—kidney cancer	3.76e-05	0.000725	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ANXA1—kidney cancer	3.76e-05	0.000725	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—FLT1—kidney cancer	3.64e-05	0.000702	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	3.61e-05	0.000697	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	3.59e-05	0.000693	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	3.59e-05	0.000693	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—POMC—kidney cancer	3.44e-05	0.000662	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PAK1—kidney cancer	3.38e-05	0.000651	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JUNB—kidney cancer	3.38e-05	0.000651	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	3.34e-05	0.000644	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	3.34e-05	0.000644	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TSC1—kidney cancer	3.34e-05	0.000644	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—FLT1—kidney cancer	3.24e-05	0.000624	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—POMC—kidney cancer	3.12e-05	0.000601	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	3.05e-05	0.000588	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PAK1—kidney cancer	3e-05	0.000578	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JUNB—kidney cancer	3e-05	0.000578	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—POMC—kidney cancer	2.77e-05	0.000534	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF2—kidney cancer	2.76e-05	0.000532	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN2B—kidney cancer	2.75e-05	0.00053	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IGF1R—kidney cancer	2.67e-05	0.000514	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—RAF1—kidney cancer	2.57e-05	0.000496	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—IL2—kidney cancer	2.54e-05	0.000489	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF2—kidney cancer	2.45e-05	0.000473	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	2.44e-05	0.00047	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	2.37e-05	0.000457	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—IL2—kidney cancer	2.31e-05	0.000444	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	2.28e-05	0.00044	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	2.26e-05	0.000435	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	2.2e-05	0.000423	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TSC2—kidney cancer	2.19e-05	0.000422	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KDR—kidney cancer	2.1e-05	0.000405	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—IL2—kidney cancer	2.05e-05	0.000395	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	1.95e-05	0.000376	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TSC2—kidney cancer	1.95e-05	0.000375	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KIT—kidney cancer	1.94e-05	0.000373	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—APC—kidney cancer	1.94e-05	0.000373	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KDR—kidney cancer	1.87e-05	0.00036	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	1.85e-05	0.000357	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—POMC—kidney cancer	1.84e-05	0.000355	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—BRAF—kidney cancer	1.82e-05	0.000351	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	1.76e-05	0.00034	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KIT—kidney cancer	1.72e-05	0.000331	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—APC—kidney cancer	1.72e-05	0.000331	CbGpPWpGaD
Phendimetrazine—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	1.69e-05	0.000325	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	1.67e-05	0.000321	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	1.65e-05	0.000317	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—POMC—kidney cancer	1.64e-05	0.000315	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—BRAF—kidney cancer	1.62e-05	0.000311	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	1.57e-05	0.000302	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	1.53e-05	0.000295	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RAF1—kidney cancer	1.52e-05	0.000293	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—RELA—kidney cancer	1.51e-05	0.000291	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	1.5e-05	0.00029	CbGpPWpGaD
Phendimetrazine—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	1.5e-05	0.000289	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MTOR—kidney cancer	1.48e-05	0.000286	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	1.48e-05	0.000285	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	1.39e-05	0.000268	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—IL2—kidney cancer	1.36e-05	0.000263	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	1.36e-05	0.000262	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	1.35e-05	0.00026	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—RELA—kidney cancer	1.34e-05	0.000259	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	1.34e-05	0.000257	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CCND1—kidney cancer	1.33e-05	0.000256	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—JUN—kidney cancer	1.33e-05	0.000255	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	1.32e-05	0.000254	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	1.32e-05	0.000253	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PTEN—kidney cancer	1.28e-05	0.000247	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	1.24e-05	0.000238	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—IL2—kidney cancer	1.21e-05	0.000233	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	1.18e-05	0.000227	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—JUN—kidney cancer	1.18e-05	0.000227	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	1.17e-05	0.000225	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	1.16e-05	0.000223	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	1.14e-05	0.000219	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	1.1e-05	0.000211	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MYC—kidney cancer	1.07e-05	0.000205	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	1.04e-05	0.000201	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.03e-05	0.000198	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—KRAS—kidney cancer	9.84e-06	0.00019	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	9.73e-06	0.000187	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MYC—kidney cancer	9.46e-06	0.000182	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	9.26e-06	0.000178	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	9.04e-06	0.000174	CbGpPWpGaD
Phendimetrazine—ADRA1B—Signaling Pathways—TP53—kidney cancer	8.75e-06	0.000169	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	8.74e-06	0.000168	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	8.03e-06	0.000155	CbGpPWpGaD
Phendimetrazine—ADRA1A—Signaling Pathways—TP53—kidney cancer	7.77e-06	0.00015	CbGpPWpGaD
